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Porphyromonas gingivalis induces RANKL in T-cells
Abstract
Porphyromonas gingivalis is an oral pathogen highly implicated in chronic periodontitis, a disease
characterized by inflammatory destruction of the tooth-supporting alveolar bone and eventually, tooth
loss. T-cell innate immune responses are actively involved in this pathological process. Receptor
activator of NF-kappaB Ligand (RANKL) is a cytokine that stimulates bone resorption, while its soluble
decoy receptor osteoprotegerin (OPG) blocks its action. This study aimed to investigate in Jurkat T-cells
the effects of P. gingivalis on the RANKL-OPG system and the major inflammatory mediator of bone
resorption prostaglandin E(2) (PGE(2)). P. gingivalis caused concentration-dependent up-regulation of
RANKL gene expression and protein production, assessed by quantitative PCR and ELISA,
respectively. PGE(2) production was also enhanced. However, OPG was not detected. In conclusion, P.
gingivalis induces RANKL and PGE(2) in T-cells, potentially favoring bone resorption. These T-cell
responses to P. gingivalis may contribute to the pathogenesis of inflammatory alveolar bone destruction
occurring in chronic periodontitis.
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ABSTRACT 
Porphyromonas gingivalis is an oral pathogen highly implicated in chronic 
periodontitis, a disease characterised by inflammatory destruction of the tooth-
supporting alveolar bone, and eventually tooth loss. T-cell innate immune responses 
are actively involved in this pathological process. Receptor Activator of NF-κB 
Ligand (RANKL) is a cytokine that stimulates bone resorption, while its soluble 
decoy receptor osteoprotegerin (OPG) blocks its action. This study aimed to 
investigate in Jurkat T-cells the effects of P. gingivalis on the RANKL-OPG system 
and the major inflammatory mediator of bone resorption prostaglandin E2 (PGE2). P. 
gingivalis caused concentration-dependent up-regulation of RANKL gene expression 
and protein production, assessed by quantitative PCR and ELISA, respectively. PGE2 
production was also enhanced. However, OPG was not detected. In conclusion, P. 
gingivalis induces RANKL and PGE2 in T-cells, potentially favouring bone 
resorption. These T-cell responses to P. gingivalis may contribute to the pathogenesis 
of inflammatory alveolar bone destruction occurring in chronic periodontitis. 
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Introduction 
Periodontal disease is potentially the most common inflammatory disease of 
infectious aetiology in humans. It is characterised by the destruction of the tooth-
supporting (periodontal) tissues, ultimately resulting in tooth loss. Porphyromonas 
gingivalis is a Gram-negative black-pigmenting anaerobe, highly implicated in human 
chronic periodontitis [1]. In vivo studies have also demonstrated that P. gingivalis can 
induce periodontitis in experimental animal models [2]. It is postulated that this oral 
pathogen can perturb the local immunity and deregulate the host inflammatory 
responses in the periodontal tissues, properties attributed to its virulence factors [3-5]. 
Due to these properties, P. gingivalis may invade into the deeper periodontal tissues 
[6] and establish chronic inflammation. 
The pathogenesis of periodontitis involves the destruction of the tooth-
supporting alveolar bone as a result of the inflammation triggered by oral bacteria. 
Early observations have outlined that the presence of lymphocytes in the 
inflammatory infiltrate of histopathological lesions of periodontitis [7]. It is now well 
established that T-cells, have a key role in the pathogenesis of periodontal disease, 
particularly by mediating the resorption of the alveolar bone [8, 9]. The notion that 
CD4+ Th1 cells are central to the cell-mediated immunity events associated with the 
disease, particularly through interferon-γ production, is now challenged by the 
discovery of the interleukin-17-producing Th17 population [10]. Although it has been 
proposed that Th17 cells confer specific osteoclast-inducing activity [11], their 
preceise role in periodontitis is still unclear. On the molecular level, the process of 
bone resorption is determined by the interplay of members of the tumor necrosis 
factor (TNF) ligand and receptor families [12]. Receptor Activator of NF-κB Ligand 
(RANKL), a member of the TNF ligand family, is expressed as cell surface-associated 
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or secreted ligand by osteoblasts, periodontal fibroblasts, as well as activated T- and 
B-cells [13]. RANKL expression can be induced by several systemic hormones and 
local inflammatory mediators, such as prostaglandin E2 (PGE2) [14]. RANKL 
activates its cognate Receptor Activator of NF-κB (RANK) receptor on monocytic 
precursors, triggering their differentiation into multinucleated bone-resorbing 
osteoclasts. Osteoprotegerin (OPG) is a soluble decoy receptor for RANKL that 
inhibits its interaction with RANK, thus preventing osteoclastogenesis and bone 
resorption [15]. The importance of these molecules in periodontal diseases has been 
demonstrated in clinical investigations [16, 17]. 
Recent work has demonstrated that P. gingivalis up-regulates RANKL and 
down-regulates OPG expression in gingival fibroblasts and periodontal ligament cells 
[18], as well as bone marrow stromal cells [19]. PGE2 is considered a potential 
mediator of P. gingivalis-induced RANKL expression [19-21]. It is also well 
established that P. gingivalis is a potent inducer of T-cell responses [22, 23]. These 
responses appear to mediate alveolar bone loss in related experimental periodontitis 
model [24, 25]. However, there is as yet no evidence on the potential effects of P. 
gingivalis on the regulation of the RANKL-OPG system in T-cells. This information 
would provide additional mechanistic insights to the role of P. gingivalis in bone 
resorption occurring in periodontitis. Therefore, the aim of this study was to 
investigate the effect of P. gingivalis on RANKL and OPG gene expression and 
protein secretion, as well as PGE2 production, in a human T-cell line. 
 
Materials and Methods 
Cell cultures 
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Jurkat T-lymphocyte leukaemia cells (E6-1; American Type Tissue Culture 
Collection) were used in this study. The cells were maintained in RPMI Glutamax 
(Gibco BRL Life Technologies) supplemented with 10% foetal bovine serum. The 
cells were cultured in suspension, at a density of 106 cells/ml. For the experiments, the 
cells were cultured in the presence or absence of ascending protein concentrations of 
P. gingivalis culture supernatants, for 6 h. 
 
Bacterial cultures and growth conditions 
Porphyromonas gingivalis W50 wild-type strain was cultured on blood agar base 
supplemented with 5% horse blood (Oxoid) and maintained by weekly subculture for 
up to 5 weeks. Liquid cultures were prepared by inoculation of bacterial colonies (3-4 
days old) from blood agar plates into 10 ml brain heart infusion broth (Oxoid) 
supplemented with 5 mg/l hemin (Sigma), and incubated for 24 h. Ten percent 
inoculum was transferred to 90 ml of the same medium and incubated for 6 days. All 
cultures were grown at 37°C in a Don Whitley anaerobic cabinet, MACS MG500, in 
an atmosphere of 80% N2, 10% H2, and 10% CO2. After this culture period, bacteria 
were harvested by centrifugation at 10000 x g for 15 min at 4˚C and supernatants 
were collected, filter-sterilized over a 0.2 µm filter, and stored at -80˚C until use.  
Protein concentration of these P. gingivalis preparations was determined by Bio-Rad 
Protein assay (Bio-Rad). For the experiments, these culture supernatants were diluted 
in the cell culture medium. Their final concentration in the experimental cell cultures 
was expressed in µg/ml.  
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Extraction of total RNA and synthesis of cDNA 
Upon termination of the experiments, total RNA was extracted from the cells using 
RNeasy Mini kit (QIAGEN) according to the manufacturer’s instructions. RNA was 
quantified using a Nanodrop spectrophotrometer and reversed transcribed into cDNA. 
One µg of total RNA was incubated with 0.5 µg/ml of oligo dT primer (Promega) at 
70°C for 5 min and cooled on ice. A master-mix was added to samples, comprising of 
10mM dNTPs, 200 units of moloney murine leukemia virus (M-MLV) reverse-
transcriptase enzyme and buffer (Promega), and dH20 to a final volume of 25 µl.  For 
the reverse-transcription reaction, these samples were incubated at 40°C for 60 min, 
70°C for 15 min and cooled down to 4°C. 
 
Quantitative real-time PCR (qPCR) 
The quantification of RANKL and OPG mRNA expression was performed by 
TaqMan® qPCR analysis using an ABI Prism 7900 HT Sequence Detection System 
and software (Applied Biosystems). For the amplification reactions a qPCR Master 
Mix was used (Abgene). The amplification conditions were 10 min at 95 °C, followed 
by 40 cycles at 95 °C for 15 sec and 60 °C for 1 min. The Gene Expression Assay 
(Applied Biosystems) IDs were: RANKL: Hs00243522-m1, OPG: Hs00171068-m1, 
GAPDH: Hs99999905-m1, and ubiquitin C (UBC): Hs01871556-m1. The relative 
expression levels of RANKL and OPG transcripts were calculated by using the 
comparative ∆Ct method (2-∆Ct formula), after normalization to the average Ct values 
of housekeeping genes UBC and GAPDH. 
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Quantification of RANKL, OPG and PGE2 levels by Enzyme Linked 
Immunosorbent Assay (ELISA) 
Upon termination of the experiments, the Jurkat T-cell cultures in suspension were 
centrifuged at 1000 rpm for 5 min. The resulting supernatants were collected for 
further analysis. Commercially available human-specific ELISA kits were used to 
quantify RANKL (Immundiagnostik), OPG (Biomedica) and PGE2 (Parameter, R&D 
Systems) in these culture supernatants. 
 
Statistical analysis 
The significance of differences between control and test groups was assessed by one-
way analysis of variance, and Bonferroni post-hoc test. P values < 0.05 were 
considered indicative of statistical significance. 
 
Results 
Jurkat T-cells were challenged with ascending protein concentrations of P. gingivalis. 
Concentrations equal or lower than 6.4 µg/ml were used, as these did not elicit any 
cytotoxic effects, as previously determined [26]. The effect on RANKL regulation 
was first investigated. The qPCR results indicate that P. gingivalis caused a 
concentration-dependent up-regulation of RANKL mRNA expression after a 6 h 
challenge period (Figure 1). The highest P. gingivalis concentration (6.4 µg/ml) 
caused a 3.7-fold up-regulation of RANKL mRNA expression, compared to the 
control. Further on, ELISA analysis revealed that RANKL protein secretion was 
concomitantly increased in the cell culture supernatants, in a concentration-dependent 
manner (Figure 2). Compared to the control, RANKL protein levels were increased by 
2.2-fold with the highest P. gingivalis concentration used.  
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The effect of P. gingivalis on the regulation of OPG, the inhibitor of RANKL, 
was also investigated in the present experimental systems. However, neither OPG 
mRNA expression, nor OPG protein secretion were detected in the cell cultures under 
these conditions, irrespective of the presence or absence of P. gingivalis challenge. 
Finally, the effect of P. gingivalis on PGE2 production was also investigated. 
The secreted PGE2 levels in the cell culture supernatants were measured by ELISA. 
After 6 h of challenge, P. gingivalis enhanced PGE2 secretion in a concentration-
dependent manner (Figure 3). The highest concentration of P. gingivalis used caused 
a 2.1-fold up-regulation, compared to the control. 
 
Discussion 
The present in vitro study has investigated the effect of P. gingivalis on the regulation 
of the RANKL-OPG system in the Jurkat T-cells. The results indicate that P. 
gingivalis induces RANKL gene expression, with concomitant RANKL protein 
production by T-cells. This is in line with previous studies demonstrating that P. 
gingivalis induces RANKL expression in gingival and periodontal ligament 
fibroblasts [18], as well as bone marrow stromal cells [19]. Therefore, the present 
finding confirms that T-cells are also responsive to P. gingivalis in terms of RANKL 
induction, among other cell types. Although in this experimental system the 
magnitude of RANKL induction appears to be modest, this osteo-immunologic 
response is not trivial. It is an important addition to the current knowledge on the 
mechanisms of pathogenesis of periodontitis, as it may provide a molecular insight to 
the T-cell mediated responses of P. gingivalis in alveolar bone resorption [24]. It is 
also interesting to note that Jurkat T-cells produce TACE in response to P. gingivalis 
challenge [26]. TACE is a metalloprotease able to shed RANKL from the cell 
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membrane surface, thus facilitating its release into the immediate extracellular 
environment and propagating its action [27]. 
The regulation of OPG was also investigated in the present experimental 
system. However, OPG expression was not detected in these cells and P. gingivalis 
challenge was not able to induce its expression. The lack of capacity by Jurkat T-cells 
to express OPG even in response bacterial challenge has previously been 
demonstrated [28], although it has also been reported that normal CD4+ T-cells can 
produce OPG [29]. This is an interesting point, as T-cell infiltrates in active 
periodontal lesions could stimulate bone resportion via RANKL, but it is not clear if 
they would be able to restore the physiological balance by compensatory OPG 
production that would inhibit osteoclastogenesis. This could potentially be contributed 
by the resident periodontal connective tissue cells. 
It is known that PGE2 has a major role in the regulation of bone resorption 
[30], with strong implication in periodontitis [31, 32]. One of the main mechanisms 
by which PGE2 is involved in bone resorption, is by triggering RANKL expression by 
a variety of cells, and therefore activating the downstream events that lead to 
osteoclast formation and activation [14].  Among other cells, Jurkat T-cells are also 
known to produce PGE2 [33-35]. It has been shown that P. gingivalis can induce 
PGE2 production in a variety of cell types, including gingival fibroblasts [36], 
epithelial cells and macrophages [37], osteoblasts [20], bone marrow stromal cells 
[19], as well as whole blood cells [38]. The present study demonstrates that P. 
gingivalis enhances PGE2 production in Jurkat T-cells as well, concomitantly to 
RANKL. This corroborates previous studies showing that PGE2 is a potential 
mediator of RANKL induction by P. gingivalis [19-21], although this remains to be 
proven in the present experimental system as well. 
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In conclusion, the present study demonstrates that P. gingivalis induces 
RANKL, but not OPG expression in Jurkat T-cells. The production of the key 
inflammatory mediator of bone resorption PGE2 is also enhanced in this experimental 
system. This indicates that P. gingivalis regulates T-cell function in a manner that 
favours osteoclastogenesis and bone resorption. These observations provide a further 
mechanistic insight on the role of T-cells in the pathogenesis of periodontal disease, 
particularly in forms that P. gingivalis is involved, such as chronic periodontitis.  
Periodontal connective tissue cells and T-cells appear to exhibit differential 
RANKL and OPG expressions. The former are resident cells that constitutively 
express OPG, but not RANKL, unless they are bacterially challenged [18]. This 
denotes a role in maintaining periodontal homeostasis, but also in contributing to 
periodontal pathogenesis. On the contrary, T-cells are found in restricted numbers in 
the healthy periodontium, but are abundant in the disease. Therefore, enhanced 
RANKL expression by these cells when present in the periodontium, may be 
detrimental for the development of periodontitis.  
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Figure Legends 
 
Figure 1. Effect of P. gingivalis on RANKL mRNA expression in Jurkat T-cells. The 
cells were challenged with ascending protein concentrations of P. gingivalis culture 
supernatants for 6 h. The mRNA expression levels of RANKL were measured by 
quantitative real-time PCR, normalized against the expression levels of the 
housekeeping genes. The results are expressed as the 2-∆Ct formula. The bars represent 
the mean values ± SEM from three independent experiments. The asterisk indicates 
statistically significant difference compared to the control group. 
 
Figure 2. Effect of P. gingivalis on RANKL protein secretion by Jurkat T-cells. The 
cells were challenged with ascending protein concentrations of P. gingivalis culture 
supernatants for 6 h. The concentrations of RANKL protein secreted into the culture 
supernatants were quantified by ELISA. The results are expressed as concentration 
detected in the cell culture supernatant (pg/ml). The bars represent the mean values ± 
SEM from three independent experiments. The asterisk indicates statistically 
significant differences compared to the control group. 
 
Figure 3. Effect of P. gingivalis on PGE2 production by Jurkat T-cells. The cells were 
challenged with ascending protein concentrations of P. gingivalis culture supernatants 
for 6 h. The concentrations of PGE2 secreted into the culture supernatants were 
quantified by ELISA. The results are expressed as concentration detected in the 
culture supernatant (pg/ml). The bars represent mean values ± SEM from three 
independent experiments. The asterisk indicates statistically significant differences 
compared to the control group. 
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